Instanosis Inc

Harm Reduction, Made Accessible.

Instanosis manufactures drug checking test strips in the USA, supporting safer choices, community programs, and overdose prevention nationwide!

06/09/2026

🚨 New Blog Post with WellLink GPO 🚨

Drug trends are evolving faster than ever, making real-time detection and harm reduction tools increasingly important. Our latest blog explores emerging substances, changing drug supply trends, and why rapid detection is becoming essential for public health and community safety.

📊 Learn about the latest trends
🔬 Explore the role of real-time detection
🤝 Support informed harm reduction efforts

View the full blog through the link in our bio.

05/12/2026

🚨 The drug supply is evolving faster than ever.

Emerging substances like xylazine, nitazenes, and medetomidine are continuing to reshape overdose response and harm reduction efforts across the U.S. As trends shift rapidly, access to timely information and real-time detection tools is becoming increasingly important for public health organizations, healthcare providers, and frontline outreach teams.

Traditional toxicology reporting can take weeks or months — but conditions in the field may change within days. Staying informed helps organizations adapt outreach, improve situational awareness, and better support their communities.

At Instanosis, we remain committed to supporting harm reduction and public health initiatives through rapid detection technologies designed to improve visibility into emerging drug trends.

💙 Rapid. Accurate. Life Saving.

04/21/2026

🚨 CDC Health Advisory

The CDC is reporting a nationwide increase in medetomidine detections in the illicit drug supply, often found alongside fentanyl and xylazine. Medetomidine is a veterinary sedative not approved for human use, adding another layer of risk and unpredictability to an already dangerous supply. View link in bio to read the full advisory.

At Instanosis, we’re supporting harm reduction with tools that help provide clarity in real time. Our 3-in-1 test strips detect fentanyl, xylazine, and medetomidine from a single sample in under 5 minutes.

🔗 www.instanosis.com

📩 [email protected]

04/14/2026

Had an incredible time at the Rx Illicit Drug Summit in Nashville! ✨

It was such a valuable experience connecting with professionals across the field, including public health officials, law enforcement, and harm reduction organizations, all working toward the same goal of improving community outcomes.

Throughout the summit, we had the opportunity to attend educational sessions led by speakers from across the space, learning more about emerging substances, evolving challenges, and the impactful work being done to support communities nationwide. It was also great to explore other booths and see the different tools and resources being offered to make a difference.

We are grateful to have been part of these conversations and to share our testing solutions with those on the front lines. Looking forward to continuing these connections and the work ahead!

03/19/2026

New independent data 👀

A third-party study from Mount Sinai found our xylazine test strips detected more positive urine samples compared to a leading competitor.

As xylazine continues to rise in the drug supply, reliable detection has never been more important.

Proud to see our technology validated in real-world clinical settings 🧪

🔗 Full study in bio

HealthcareInnovation

03/18/2026

Something big is coming in 2026 👀✨

Introducing our upcoming 12-Panel Multi-Drug Detection Kit — designed to detect 12 substances from a single sample in under 5 minutes ⚡🧪

Built for speed, simplicity, and real-world use, this kit is compatible with powders, liquids, tablets, crystals, and surface residues 🔬💧

Perfect for:
✔️ Forensic investigations 🕵️‍♂️
✔️ Research laboratories 🧬
✔️ Law enforcement 🚔
✔️ Toxicology labs 🧫

One sample. More answers. Faster decisions.

Launching 2026 — stay tuned 👀🚀

📩 For more information: [email protected]

DrugChecking Innovation MedTech Instanosis

03/16/2026

Nashville, we’re coming. 🤠

The Instanosis team will be attending the Rx and Illicit Drug Summit from April 6–9, one of the largest gatherings focused on addressing the overdose crisis.

Harm reduction conferences like this bring together public health leaders, community organizations, clinicians, and policymakers to share strategies that save lives and expand access to prevention tools.

We’re excited to connect, learn, and continue advancing solutions that support safer communities.

Stay tuned for updates from Nashville.

02/26/2026

Your feedback truly means the world to us 💙

Whether you’ve purchased our products on Amazon, worked with our team, or simply heard about Instanosis through the community — your voice helps us grow, improve, and continue building tools that support harm reduction and safer testing.

If you’ve had any experience with our products, we would be incredibly grateful if you shared a kind review or a few words of feedback. Even a short comment helps others learn more about what we do and allows us to keep improving for the people who rely on us every day 🤝

⭐ Leave a review or explore our Amazon Brand Store:
https://www.amazon.com/stores/INSTANOSIS/page/8B32177D-6EBB-4F2B-A272-6AE5BBC14911?lp_asin=B0FQK2GH41&ref_=cm_sw_r_apin_ast_store_AC5GN06465Q007MZG5CT&store_ref=bl_ast_dp_brandLogo_sto

Thank you for supporting Instanosis and being part of a community that cares.

For more information or questions:
[email protected]

Address

1004 W Ninth Avenue
King Of Prussia, PA
19046

Website

http://www.instanosis.com/, https://journalofscientificinnovationinmedicine.org/articles/10.29024/jsim.261

Alerts

Be the first to know and let us send you an email when Instanosis Inc posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Want your business to be the top-listed Business in King of Prussia?